Anacor files $50 million shelf covering stock, preferreds and debt

By Devika Patel

Knoxville, Tenn., Dec. 28 - Anacor Pharmaceuticals, Inc. filed a $50 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities and warrants.

The securities may be structured as convertibles.

Proceeds will be used for research and development activities, including preclinical studies and clinical trials, to increase the company's working capital and for general corporate purposes.

The pharmaceutical company is based in Palo Alto, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.